17 September 2015
© Commonwealth of Australia 2015 ISBN 978-1-76010-224-1
View the report as a single document - (PDF 933KB)
View the report as separate downloadable parts:
Access to cancer drugs in Australia The inquiry The structure of the report The incidence of cancer in Australia Cancer as a national health priority Assessment of cancer medicines in Australia Alternate access schemes Comparable international models
Timelines for access to new medicines in Australia
The PBAC assessment framework Evaluation of cost Evidentiary requirements Measuring quality of life - assessing the value of cancer medicines Committee view
The impact of delayed access on cancer patients and their families Alternative pathways for access to cancer drugs Impact on rural patients Impact on patients with rare cancers Impact on children, adolescents and young adults Committee view
Establishment of a specialist cancer drug fund Managed access models Improved monitoring and data collection Committee view
Enhancing the operation of the TGA and the PBAC The need for a coordinated review of access pathways for cancer medicines
Committee SecretarySenate Standing Committees on Community AffairsPO Box 6100Parliament HouseCanberra ACT 2600 Phone: +61 2 6277 3515community.affairs.sen@aph.gov.au
An inquiry into the availability of new, innovative and specialist cancer drugs in Australia.
20 Apr 2015: Canberra
Senate
House of Representatives
Get informed
Bills
Committees
Get involved
Visit Parliament
Website features
Parliamentary Departments